ENG/中
老虎證券
行情
产品介绍
Cash Boost账户
美股
美股碎股
港股
A股通
期权
期货
美国国债
定投
固定票息票据
Tiger BOSS Debit Card
基金超市
老虎钱袋子
老虎API平台
Wealth
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
专栏
TigerAI
机构
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
登入
立即註冊
Toggle
美股
詳情
本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務
Medidata
92.22
+0.0000
成交量:
- -
成交額:
- -
市值:
55.68億
市盈率:
128.09
高:
92.22
開:
92.22
低:
92.22
收:
92.22
資料載入中...
總覽
公司
新聞
公告
公司資料
公司名字:
Medidata
交易所:
NASDAQ
成立時間:
- -
員工人數:
- -
公司地址:
- -
官網:
http://www.mdsol.com
郵編:
- -
電話:
- -
傳真:
- -
簡介:
Medidata Solutions, Inc.於1999年6月在紐約成立,並於2000年5月在特拉華州重組。該公司是為生命科學提供基於雲計算的解決方案的全球領先供應商,從客戶的計劃到試驗結果,提高臨床開發過程的效率,從而優化客戶在研究和開發方面的投資。該公司的客戶包括製藥、生物技術和醫療器械公司、學術機構、合同研究機構(即CROs)和其它從事於醫療產品和治療方案的臨床試驗從而實現為尋找新適應症進行探索的組織機構。其解決方案能夠使客戶通過更有效地設計、規劃並管理臨床試驗過程的關鍵環節實現發展計劃的價值增值。這些關鍵環節包括研究和方案設計、試驗規劃和預算、現場談判、臨床門戶網站、隨機化和試驗供應管理、臨床數據採集和管理、安全性事件捕捉、醫療編碼、臨床業務分析、數據流和多個試驗的互操作性。其客戶依靠其解決方案能夠安全地加快臨床開發過程,從而加強決策並節約開發周期中的資源。該公司的大部分收入源於 Medidata Rave應用服務在特定數目研究中的互研究的應用。
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/MDSO/company"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"MDSO","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MDSO\",,,,,undefined,":{"symbol":"MDSO","market":"US","secType":"STK","nameCN":"Medidata","latestPrice":92.22,"timestamp":1572292800000,"preClose":92.22,"halted":4,"volume":0,"delay":0,"floatShares":58012972,"shares":60380410,"eps":0.719941,"marketStatus":"退市","change":0,"latestTime":"04-29 15:51:56 EDT","open":92.22,"high":92.22,"low":92.22,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0.719941,"tradingStatus":0,"nextMarketStatus":{"tag":"盤後交易","tradingStatus":3,"beginTime":1745956800000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":1245902400000,"exchange":"NASDAQ","adjPreClose":92.22,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MDSO\",,,,,undefined,":{"symbol":"MDSO","floatShares":58012972,"roa":"2.18%","roe":"7.21%","lyrEps":0.893264,"shares":60380410,"dividePrice":0,"high":92.22,"amplitude":0,"preClose":92.22,"low":92.22,"week52Low":60.1,"pbRate":"8.43","week52High":98.6,"institutionHeld":0,"latestPrice":92.22,"eps":0.719941,"divideRate":0,"volume":0,"delay":0,"ttmEps":0.719941,"open":92.22},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://www.mdsol.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":0.0719},{"period":"1month","weight":-0.0087},{"period":"3month","weight":-0.0888},{"period":"6month","weight":-0.0503},{"period":"1year","weight":0.0838},{"period":"ytd","weight":-0.0601}],"compareStock":{"symbol":"SPY","name":"標普500ETF"},"description":"Medidata Solutions, Inc.於1999年6月在紐約成立,並於2000年5月在特拉華州重組。該公司是為生命科學提供基於雲計算的解決方案的全球領先供應商,從客戶的計劃到試驗結果,提高臨床開發過程的效率,從而優化客戶在研究和開發方面的投資。該公司的客戶包括製藥、生物技術和醫療器械公司、學術機構、合同研究機構(即CROs)和其它從事於醫療產品和治療方案的臨床試驗從而實現為尋找新適應症進行探索的組織機構。其解決方案能夠使客戶通過更有效地設計、規劃並管理臨床試驗過程的關鍵環節實現發展計劃的價值增值。這些關鍵環節包括研究和方案設計、試驗規劃和預算、現場談判、臨床門戶網站、隨機化和試驗供應管理、臨床數據採集和管理、安全性事件捕捉、醫療編碼、臨床業務分析、數據流和多個試驗的互操作性。其客戶依靠其解決方案能夠安全地加快臨床開發過程,從而加強決策並節約開發周期中的資源。該公司的大部分收入源於 Medidata Rave應用服務在特定數目研究中的互研究的應用。","exchange":"NASDAQ","name":"Medidata","nameEN":"Medidata Solutions"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"MDSO\",market:\"US\",,,undefined,":null,"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MDSO\",params:#limit:5,,,undefined,":[{"date":"2019-10-31","symbol":"MDSO","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":"2019/09","expectedEps":0.22,"defaultRemindTime":1572508800000,"name":null,"time":"盤前","dateTimestamp":1572494400000,"actualEps":0.21},{"market":"US","date":"2019-10-29","symbol":"MDSO","fiscalQuarterEnding":"2019/09","expectedEps":0.47,"name":null,"time":"盤前","type":"earning","dateTimestamp":1572321600000,"reportTimeType":"pre","actualEps":0.21},{"date":"2019-07-23","symbol":"MDSO","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":"2019/06","expectedEps":0.39,"defaultRemindTime":1563912000000,"name":null,"time":"盤後","dateTimestamp":1563854400000,"actualEps":0.24},{"market":"US","date":"2019-04-30","symbol":"MDSO","fiscalQuarterEnding":"2019/03","expectedEps":0.12,"name":null,"time":"盤前","type":"earning","dateTimestamp":1556596800000,"reportTimeType":"pre","actualEps":0.2},{"market":"US","date":"2019-02-12","symbol":"MDSO","fiscalQuarterEnding":"2018/12","expectedEps":0.16,"name":null,"time":"盤前","type":"earning","dateTimestamp":1549947600000,"reportTimeType":"pre","actualEps":0.26}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MDSO\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"MDSO\",market:\"US\",delay:false,,,undefined,":{}}}